Citation Impact
Citing Papers
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Treml4, an Ig Superfamily Member, Mediates Presentation of Several Antigens to T Cells In Vivo, Including Protective Immunity to HER2 Protein
2011 StandoutNobel
The DNA-damage response in human biology and disease
2009 StandoutNature
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential
2004
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
2009
Pathogenesis of human systemic lupus erythematosus: recent advances
2010
Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells
2001
Erythrocyte survival is controlled by microRNA-142
2016
The Thrombospondins
2011 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Late toxicity following curative treatment of testicular cancer
1999
Pattern recognition receptors in the immune response against dying cells
2008
Involvement of the DNA mismatch repair system in antineoplastic drug resistance
1999
Mechanisms of therapy-related carcinogenesis
2005
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Cisplatin Nephrotoxicity: A Review
2007 Standout
Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa
1991
Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24‐color FISH
2002
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Metazoan MicroRNAs
2018 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
2002
Cellular processing of platinum anticancer drugs
2005 Standout
Mismatch repair and response to DNA-damaging antitumour therapies
2003
Systemic Lupus Erythematosus
2011 Standout
Human mismatch repair, drug-induced DNA damage, and secondary cancer
2003
Current management of motor fluctuations in patients with advanced Parkinson’s disease treated chronically with levodopa
1999
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Genetic Pathways in the Pathogenesis of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
2007
Molecular mechanisms of necroptosis: an ordered cellular explosion
2010 Standout
Microsatellite Instability in Human Cancer: A Prognostic Marker for Chemotherapy?
1999
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
2001
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
2010
The role of senescent cells in ageing
2014 StandoutNature
Configuration of the TP53 Gene as an Independent Prognostic Parameter of Myelodysplastic Syndrome
2003
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
2008
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Molecular mechanisms of late apoptotic/necrotic cell clearance
2009
Effect of cisapride on response fluctuations in Parkinson's disease
1995
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance
2007
Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia
2007
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities
1998
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
2005 StandoutNobel
Thrombospondin 1 binding to calreticulin‐LRP1 signals resistance to anoikis
2008
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction
2005 Standout
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
New photosensitizers for photodynamic therapy
2016 Standout
Repopulating defect of mismatch repair–deficient hematopoietic stem cells
2003
HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory
2019
Human DNA Repair Genes
2001 StandoutScienceNobel
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy‐related leukemia
2015
Works of Orly Zelig being referenced
Monotherapy with Rituximab Induces Rapid Remission of Recurrent Cold Agglutinin-Mediated Hemolytic Anemia in a Patient with Indolent Lympho-Plasmacytic Lymphoma
2001
Episodic unresponsiveness to single doses of L‐dopa in parkinsonian fluctuators
1986
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype
1996
Storage-Induced Damage to Red Blood Cell Mechanical Properties Can Be Only Partially Reversed by Rejuvenation
2014
Delayed Onset of Responses to Single Doses of L-Dopa in Parkinsonian Fluctuators on Long-Term L-Dopa Therapy
1986
Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states
2006